Rewriting Drug Discovery with ADAPTx

ADAPTx, developed by ADAPTherapeutics, is an innovative drug discovery platform combining state-of-the-art laboratories, high-throughput screening, and expertise in molecular and cell biology, functional genomics, and computational analysis. ADAPTx identifies compounds that can reverse aging-related phenotypes through transcriptomic reprogramming. The workflow integrates dose-response assays, high-throughput RNA-seq, and computational analysis to prioritize candidates for subsequent preclinical validation. By leveraging advanced technologies such as single-cell and spatial transcriptomics, our approach dissects molecular mechanisms and cellular pathways affected in complex biological systems.